The association of serum total and high density lipoprotein cholesterol values with 15 year mortality was examined in a cohort of 10 059 Israeli male civil servants and municipal employees aged 40 and above. In 618 of 1664 deaths in the cohort (37%) coronary heart disease was documented as the cause of death. Risk of mortality was analysed by quintiles. Neither total mortality nor coronary heart disease mortality rose with serum cholesterol concentrations up to 5-6 mmol/l (216 mg/ 100 ml), representing 60% of the sample. Rates rose appreciably only in the highest quintile (cholesterol concentration >6 2 mmolil; >241 mg/100 ml). High density lipoprotein cholesterol was similarly, although inversely, associated with total mortality when expressed as a percentage of total cholesterol. The inverse association of high density lipoprotein cholesterol with coronary heart disease mortality was, in contrast, continuous. These data support the hypothesis that over most of the range of cholesterol values coronary mortality risk and total mortality risk are nearly independent of total cholesterol and most probably independent of low density lipoprotein cholesterol values.
was documented as the cause of death. Risk of mortality was analysed by quintiles. Neither total mortality nor coronary heart disease mortality rose with serum cholesterol concentrations up to [5] [6] mmol/l (216 mg/ 100 ml), representing 60% of the sample. Rates rose appreciably only in the highest quintile (cholesterol concentration >6 2 mmolil; >241 mg/100 ml). High density lipoprotein cholesterol was similarly, although inversely, associated with total mortality when expressed as a percentage of total cholesterol. The inverse association of high density lipoprotein cholesterol with coronary heart disease mortality was, in contrast, continuous. These data support the hypothesis that over most of the range of cholesterol values coronary mortality risk and total mortality risk are nearly independent of total cholesterol and most probably independent of low density lipoprotein cholesterol values.
In multivariate analysis a low concentration of high density lipoprotein cholesterol appeared to be more predictive of mortality than a high concentration of total cholesterol. The latter was very weakly related to mortality from all causes after multivariate adjustment.
It is concluded that the findings of this and other major epidemiological studies support the notion of a Introduction The Lipid Research Clinics Program of the National Heart, Lung, and Blood Institute has recently achieved success in reducing cardiac mortality and the incidence of non-fatal myocardial infarction in hypercholesterolaemic men with the use of cholestyramine resin.' This result is certain to increase both the fervour of supporters of the "cholesterol connection" and the controversy2 associated with advocating large scale dietary reforms in populations.
One of the numerous aspects of the controversy concerns the nature of the association between cholesterol and coronary heart disease. Those citing mainly "ecological correlations" have pointed out that mean concentrations of cholesterol were low in countries with a low incidence of coronary heart disease and that this proves the wisdom of reducing cholesterol concentrations across the board.3 Such cross cultural correlations are, however, compatible with two settings-namely, that in which individual values within a society are correlated with risk of coronary heart disease along the whole range of cholesterol concentrations and that in which the risk of coronary heart disease is raised only in subjects with exceptionally high cholesterol concentrations.
A major controversy appears to surround this question5-' and has profound ramifications for public health; for if a threshold exists below which it is not beneficial (in terms of risk of coronary heart disease) to reduce concentrations of cholesterol in the blood,9 the case for the population strategy'0 is considerably weakened. A clear cut reduction in the incidence of coronary heart disease by dietary measures has been achieved only by the Oslo study group," with a mean cholesterol concentration above 7-8 mmol/l (300 mg/100 ml). The reduction associated with the use of cholestyramine resin was achieved in a sample of men with concentrations above 6 9 mmol/l (265 mg/ 100 ml) and cannot be automatically extrapolated to another form of intervention, limited to dietary measures, applied over the whole cholesterol range and for both men and women.
We have used data collected in the Israeli Ischaemic Heart Disease Study to analyse results pertaining to the controversy and examine their relevance.
Methods
In 1963 we measured the concentrations of cholesterol in the serum of 9902 male civil servants and municipal employees aged 40 and over."2 In 6547 of these the concentrations of both total cholesterol and high density lipoprotein cholesterol were assessed.
The distribution of total serum cholesterol and its association with other variables have been reported."3 Venous blood was drawn from non-fasting men after electrocardiography and physical examination but before a psychosocial and dietary survey; this was to avoid any possible stressful effect of questioning on cholesterol and blood glucose concentrations or blood pressure. Blood was collected in three vacutainer tubes, one of which was a 20 ml tube, to which anticoagulant was not added, for collection of serum. Blood samples were kept refrigerated and taken daily in ice cooled containers to a central laboratory, where the tubes were centrifuged, the serum separated, and cells discarded. (22 0) 189 491 (29 5) 1664 (100 0) 10-4 and 13.1 x 10-4) terms were significantly different from zero (p<001). The significance of the latter implies that the association between cholesterol and mortality departs significantly from linearity. The figure shows that the quadratic model fits the data somewhat better than the exponential one, although both fail to account fully for the total lack of rising mortality trend in the lowest deciles.
HIGH DENSITY LIPOPROTEIN CHOLESTEROL Table V gives the age adjusted mortality rates for each quintile of high density lipoprotein cholesterol expressed both in absolute concentration and as a percentage of the total serum cholesterol concentration. The rates declined noticeably. As a rule, associations of mortality (total or due to coronary heart disease) with high density lipoprotein cholesterol are reinforced when the latter is expressed as a percentage of total cholesterol. The lowest quintile/highest quintile age adjusted relative risk was 3 70. Table VI shows the age specific association of high density lipoprotein cholesterol as a percentage of total cholesterol with mortality. The largest decrement of total mortality appeared to be associated with avoidance of quintile I (high density lipoprotein cholesterol < 14%o). (27) Age specific death rates from coronary heart disease given in parentheses. 
Discussion
The relation between the serum cholesterol concentration and the incidence of atherosclerosis is unresolved and of major importance. Realistically the question must be approached by studying the association of cholesterol with coronary heart disease morbidity or mortality rates.
In practical terms the major issue is whether a sweeping attempt to lower the mean cholesterol concentration of populations is justified. In terms of the message often delivered to the public, the following question might be put: Should everyone eat as though he (or she) is prone to hyperlipidaemia? On the basis of our results it would appear that at concentrations below 6-2 mmol/l (240 mg/100 ml), and certainly below 5-7 mmol/l (220 mg/100 ml), there is little or no association between cholesterol concentration and risk of mortality from coronary heart disease. Whether the link is fully with incidence or partly mediated through case fatality we cannot judge with certainty. Of equal relevance in our opinion is judging the efficacy of reducing cholesterol against the yardstick of the reduction in total mortality. Our results are not very suggestive when this latter criterion is applied. Even in the recent, widely publicised Lipid Research Clinics primary prevention study of the National Heart, Lung, and Blood Institute no significant reduction of overall mortality was achieved (the reduction was 7%), although the authors did not attribute major importance to that point, the difference being due to excess traumatic deaths in the drug treated group. ' Several population studies have detected associations between cholesterol and coronary heart disease that closely resemble our results.'8" Keys pointed out that the sweeping use of multivariate analysis has led to the observing of L shaped or J shaped associations by forcing the association into the best fit with linearity.7 This best fit may often be poor. To avoid the temptation to "smooth at all cost" we need to look at tertiles, quintiles, or deciles, as the magnitude of the numbers permits.
I
Our results offer little support for the "population strategy." Although many cases of coronary heart disease will occur among those at low or moderate risk, our knowledge about the determinants of coronary heart disease incidence and mortality is far from adequate, and the widely varying results of recent multiple intervention studies are evidence of this gap in our knowledge.2' Hence we cannot recommend a policy of reducing the mean cholesterol concentration in populations to [4] [5] [6] [7] mmol/l (180 mg/100 ml), which in any case would be a major, if not impossible task. We therefore concur that a policy of selective intervention should be followed and that the cholesterol concentration should be reduced, if possible, in those in whom it is definitely raised, with means of attempting the reduction (dietetic, pharmacological) tailored individually. This might preclude the exposure of a large section of the population to potential drug hazard.
A special feature of our study was the availability of data for a long term association of mortality with high density lipoprotein cholesterol. The latter variable was related to mortality from coronary heart disease in a near perfect linear manner when analysis was performed in quintiles of the relative (high density lipoprotein/total) lipid values. Lowest quintile/highest quintile relative risk was 3 7, as compared with the highest quintile/lowest quintile relative risk of only 2 3 for total cholesterol.
If high density lipoprotein cholesterol is the major lipid determinant of long term coronary heart disease and total mortality and the ratio of high density lipoprotein cholesterol to total cholesterol is the better identifier of risk, as we have suggested24 and as the present univariate and multivariate analyses suggest, the prospects for modifying coronary heart disease risk merely through recommendations to whole populations to introduce massive dietary changes are poor. Recently, parallel changes in high density lipoprotein and total cholesterol, under dietary control, were observed in Finland. 25 The effect of cholestyramine resin may have been primarily due to the success of introducing pharmacological intervention that reduced low density lipoprotein while avoiding a parallel decline in high density lipoprotein and thus causing major changes in individual high density lipoprotein to low density lipoprotein ratios.
A final point is related to the widespread opinion that, at least across populations, the lower the mean cholesterol concentration the lower the risk of coronary heart disease. The example of the Israeli women who, despite a mean plasma cholesterol concentration of under 5-2 mmol/l (200 mg/100 ml),26 rank so high on the international mortality list27 is a reminder that high cholesterol values and coronary heart disease are not synonymous. Data for women were clearly ignored or discarded when the "ecological" type of diet-cholesterol-coronary heart disease argument was proposed. Inconsistencies may stem from unrecognised interactions among environment, sex, and other genetic factors.28 29 In conclusion, these data from the 15 year follow up of the Israeli Ischaemic Heart Disease Study support the "threshold theory" for the association between cholesterol and mortality, suggest that high density lipoprotein cholesterol might be a key variable, and provide a further indication that the unqualified recommendation for mass dietary changes in whole populations may be premature.
C BARTHOLOMEW, W CHARLES, C SAXINGER, W BLATTNER, M ROBERT-GUROFF, C RAJU, P RATAN, W INCE, D QUAMINA, K BASDEO-MAHARAJ, R C GALLO Abstract Adult T cell leukaemia/lymphoma was first recognised as a clinical entity in southwest Japan. Subsequently the Caribbean has been found to be another area where the disease is endemic, and sporadic cases have been identified in different parts of the world. The human T cell leukaemia/lymphoma virus (HTLV-I) is causally related to adult T cell leukaemia/lymphoma. A subgroup of HTLV, designated HTLV-III, has recently been isolated from many patients with the acquired immunodeficiency syndrome (AIDS) and preAIDS, and there is now evidence that this variant is the primary cause of AIDS. This is the first report from Trinidad to describe 12 cases of adult T cell leukaemia/lymphoma and 14 of AIDS. All were in patients of African descent. No cases were seen in subjects of East Indian descent, who, like those of African descent, comprise as much as 40% of the population. 
Introduction
Retroviruses have been linked to leukaemia in many animal species, and the search for a human retrovirus was first accomplished with the discovery of a type C retrovirus of truly human origin by Gallo and coworkers, which was quite distinct from any known animal retrovirus. This agent, the human T cell leukaemia/lymphoma virus type I (HTLV-I), was initially isolated from two black adults said to have mycosis fungoides and the Sezary syndrome' I but who in retrospect had adult T cell leukaemia/lymphoma.
The link of HTLV-I to this clinical entity was made in serological studies of Japanese patients with adult T cell leukaemia/lymphoma, by the recognition that HTLV-I associated patients in the United States had this syndrome, and by the observation of the clinical syndrome in six black patients in London who originated from the West Indian islands St Vincent, Grenada, and Trinidad and from Guyana,3 all of whom were shown to be positive for HTLV-I antibodies.4 Before this, no such cases had been reported in West Indians living in the West Indies.
Subsequently the detection of antibody positive carriers in the region supported the concept that the West Indies are an HTLV-I endemic region.5 Further support for this concept has come from studies in Jamaica,6 where 11 (69%) of 16 consecutive patients with non-Hodgkin's lymphoma newly diagnosed between 1 February 1982 and 31 January 1983 had antibodies to HTLV-I in their sera.
A retroviral aetiology for the acquired immune deficiency syndrome (AIDS) was suggested initially by the finding of antibodies to HTLV-I in a high proportion of patients with AIDS, using an HTLV-I membrane antigen assay.7 AIDS is, however, rare or absent in most areas where HTLV-I is endemic. This discrepancy has been clarified by the recent
